This topic contains a solution. Click here to go to the answer

Author Question: The ability to continue the employment of qualified individuals, that is, nurses and/or other health ... (Read 21 times)

EY67

  • Hero Member
  • *****
  • Posts: 531
The ability to continue the employment of qualified individuals, that is, nurses and/or other health care providers/associates who might otherwise leave the organization is called:
 
  a. transfer.
  b. selection.
  c. turnover.
  d. retention.

Question 2

The first 6 months have been shown to be the most stressful adjustment period for nurses.
 
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Galvarado142

  • Sr. Member
  • ****
  • Posts: 348
Answer to Question 1

D
Retention is the ability to continue the employment of qualified individuals, that is, nurses and/or other health care providers/associates who might otherwise leave the organization. The impact of this action is to maintain stability and enhance quality of care while reducing cost to the organi-zation.

Answer to Question 2

T




EY67

  • Member
  • Posts: 531
Reply 2 on: Jul 7, 2018
Excellent


bimper21

  • Member
  • Posts: 309
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Amphetamine poisoning can cause intravascular coagulation, circulatory collapse, rhabdomyolysis, ischemic colitis, acute psychosis, hyperthermia, respiratory distress syndrome, and pericarditis.

Did you know?

It is believed that humans initially contracted crabs from gorillas about 3 million years ago from either sleeping in gorilla nests or eating the apes.

Did you know?

Parkinson's disease is both chronic and progressive. This means that it persists over a long period of time and that its symptoms grow worse over time.

Did you know?

The longest a person has survived after a heart transplant is 24 years.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library